1-methyl-4-cyclohexyl-1,2,3,6-tetrahydropyridine has been researched along with monocrotaline in 1 studies
| Studies (1-methyl-4-cyclohexyl-1,2,3,6-tetrahydropyridine) | Trials (1-methyl-4-cyclohexyl-1,2,3,6-tetrahydropyridine) | Recent Studies (post-2010) (1-methyl-4-cyclohexyl-1,2,3,6-tetrahydropyridine) | Studies (monocrotaline) | Trials (monocrotaline) | Recent Studies (post-2010) (monocrotaline) |
|---|---|---|---|---|---|
| 7 | 0 | 3 | 1,746 | 3 | 850 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mukhopadhyay, S; Sehgal, PB | 1 |
1 other study(ies) available for 1-methyl-4-cyclohexyl-1,2,3,6-tetrahydropyridine and monocrotaline
| Article | Year |
|---|---|
Discordant regulatory changes in monocrotaline-induced megalocytosis of lung arterial endothelial and alveolar epithelial cells.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Cell Division; Cell Line; Cell Separation; Endoplasmic Reticulum Chaperone BiP; Humans; Interleukin-6; Monocrotaline; Pulmonary Alveoli; Pulmonary Artery; Respiratory Mucosa; STAT3 Transcription Factor; Transcription, Genetic | 2006 |